News Room

A collection of press releases, audio content and media clips featuring INFORMS members and their research.

New AI-Driven Model Could Revolutionize Conservation Efforts for Endangered Species
News Release

BALTIMORE, MD, May 8, 2025 – A new study published in the INFORMS journal Management Science introduces a data-driven strategy that is already beginning to change the way conservationists locate and protect endangered species in the U.S., which can be adopted worldwide.

Read More
China’s rare earth minerals power the modern world. Banning their export could destroy it
Media Coverage

Beijing has a virtual monopoly on rare earth minerals—the materials that power everything from military planes to your electric toothbrush.

Read More
Trump’s tech tariff confusion
Media Coverage
The Trump administration’s back-and-forth moves on tariffs for technology products are stirring confusion in a sector heavily reliant on global supply chains.  
Read More

Resoundingly Human Podcast

An audio journey of how data and analytics save lives, save money and solve problems.

Media Contact

Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578

INFORMS in the News

What are you looking for?

Type of Content
Topic
Potential of mixing and matching COVID-19 vaccines

Potential of mixing and matching COVID-19 vaccines

Our Community Now, October 19, 2021

There was not any vote taken about mixing and matching,” said N.C. State/public health scientist Dr. Julie Swann. The official guidance is to get the same vaccine for your COVID vaccine booster dose as you did previously.

New Data-Driven Approaches Would Improve How FDA Monitors Safety of Approved Drugs

New Data-Driven Approaches Would Improve How FDA Monitors Safety of Approved Drugs

ACRP, October 18, 2021

New research in the INFORMS journal Management Science finds that the U.S. Food and Drug Administration (FDA) could enhance public safety by employing new data-driven approaches to identify adverse effects of drugs faster and more reliably, which would improve the regulatory decision-making and oversight processes. This approach would substantially contrast with the current FDA approaches for monitoring drug safety, which suffers major drawbacks (e.g., they are based on voluntary reports that can result in inaccurate or untimely decisions).

Subject Matter Experts in

Supply Chain

View list of experts

Subject Matter Experts in

Healthcare

View list of experts

INFORMS Magazines

OR/MS Today is the INFORMS member magazine that shares the latest research and best practices in operations research, analytics and the management sciences.

Access OR/MS Today Magazine

Analytics magazine showcases articles and research reports based on big data, AI, machine learning, data analytics and other new-age technologies.

Access Analytics Magazine